Melqart Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-172,949
| Closed | -$14.2M | – | 50 |
|
|
2024
Q2 | $14.2M | Buy |
+172,949
| New | +$14.2M | 1.18% | 24 |
|
|
2022
Q4 | – | Sell |
-155,849
| Closed | -$13.2M | – | 40 |
|
|
2022
Q3 | $13.2M | Sell |
155,849
-11,012
| -7% | -$933K | 1.01% | 39 |
|
|
2022
Q2 | $13.8M | Sell |
166,861
-163,401
| -49% | -$13.5M | 1.07% | 30 |
|
|
2022
Q1 | $25.5M | Sell |
330,262
-173,357
| -34% | -$13.4M | 1.7% | 20 |
|
|
2021
Q4 | $44.5M | Sell |
503,619
-99,181
| -16% | -$8.76M | 2.26% | 9 |
|
|
2021
Q3 | $46.6M | Buy |
602,800
+152,000
| +34% | +$11.7M | 2.23% | 12 |
|
|
2021
Q2 | $37.6M | Buy |
450,800
+123,000
| +38% | +$10.3M | 1.69% | 20 |
|
|
2021
Q1 | $24.8M | Buy |
+327,800
| New | +$24.8M | 1.12% | 24 |
|